{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colloid&page=13", "query": { "intervention": "Colloid", "page": 13 }, "page_size": 10 }, "pagination": { "page": 13, "page_size": 10, "total_count": 338, "total_pages": 34, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colloid&page=14&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colloid&page=12&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T13:11:38.364Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06568627", "title": "A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Leg Ulcer (VLU)" ], "interventions": [ { "name": "EscharEx (EX-03)", "type": "DRUG" }, { "name": "Placebo (Gel vehicle)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediWound Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 216, "start_date": "2025-06-01", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Fresno, California • Los Angeles, California + 15 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568627" }, { "nct_id": "NCT00231153", "title": "Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infection" ], "interventions": [ { "name": "Omiganan 1% gel", "type": "DRUG" }, { "name": "Povidone-Iodine 10%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cadence Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 1859, "start_date": "2005-08", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2009-08-13", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 36, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Arcadia, California + 33 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Arcadia", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00231153" }, { "nct_id": "NCT01276054", "title": "Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphedema", "Recurrent Breast Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer" ], "interventions": [ { "name": "technetium Tc 99m sulfur colloid", "type": "RADIATION" }, { "name": "methylene blue", "type": "DRUG" }, { "name": "indocyanine green solution", "type": "DRUG" }, { "name": "sentinel lymph node biopsy", "type": "PROCEDURE" }, { "name": "axillary lymph node biopsy", "type": "PROCEDURE" }, { "name": "bioimpedance spectroscopy", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" }, { "name": "lymphedema management", "type": "OTHER" } ], "intervention_types": [ "RADIATION", "DRUG", "PROCEDURE", "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 4, "start_date": "2010-12", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2014-08-01", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01276054" }, { "nct_id": "NCT01028677", "title": "Oxytocin Treatment of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Paranoia", "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "intranasal spray with oxytocin", "type": "DRUG" }, { "name": "nasal spray without oxytocin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 17, "start_date": "2009-11", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2017-04-18", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01028677" }, { "nct_id": "NCT02446886", "title": "Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2016-06", "completion_date": "2020-06", "has_results": true, "last_update_posted_date": "2021-01-22", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02446886" }, { "nct_id": "NCT05657496", "title": "Biological Response to Platelet-rich Plasma and Corticosteroid Injections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Triamcinolone Acetonide 40 mg/ml Inj, Susp", "type": "DRUG" }, { "name": "Platelet-rich plasma Inj", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 23, "start_date": "2022-12-28", "completion_date": "2025-06-18", "has_results": false, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05657496" }, { "nct_id": "NCT01138735", "title": "Epiduo Pediatric Acne Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne" ], "interventions": [ { "name": "adapalene/benzoyl peroxide", "type": "DRUG" }, { "name": "Topical Gel Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "9 Years to 11 Years" }, "enrollment_count": 285, "start_date": "2010-06", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 20, "location_summary": "Birmingham, Alabama • San Diego, California • Santa Rosa, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Miramar", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01138735" }, { "nct_id": "NCT03649724", "title": "The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer Disease", "Mild Cognitive Impairment" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Eligard 22.5Mg Suspension for Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "60 Years to 120 Years · Female only" }, "enrollment_count": 86, "start_date": "2020-11-27", "completion_date": "2026-07-25", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 3, "location_summary": "Boca Raton, Florida • New York, New York • Madison, Wisconsin", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03649724" }, { "nct_id": "NCT00450723", "title": "Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Isosulfan blue", "type": "DRUG" }, { "name": "Axillary Lymph Node Dissection", "type": "PROCEDURE" }, { "name": "Surgery", "type": "PROCEDURE" }, { "name": "Sentinel Lymph Node Biopsy", "type": "PROCEDURE" }, { "name": "Thoracoscopic Surgery", "type": "PROCEDURE" }, { "name": "Technetium Tc 99m Sulfur Colloid", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 39, "start_date": "2004-05", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2017-02-07", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00450723" }, { "nct_id": "NCT05626621", "title": "Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Rhinitis" ], "interventions": [ { "name": "Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray", "type": "DRUG" }, { "name": "Mometasone Nasal Irrigation (1 mg capsule)", "type": "DRUG" }, { "name": "Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 81, "start_date": "2022-11-23", "completion_date": "2026-08", "has_results": false, "last_update_posted_date": "2023-07-28", "last_synced_at": "2026-10-23T13:11:38.364Z", "location_count": 1, "location_summary": "Evanston, Illinois", "locations": [ { "city": "Evanston", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05626621" } ] }